Scott C, Sawhney S, Lewandowski LB. Pediatric Rheumatic Disease in Lower to Middle-Income countries: impact of global disparities, ancestral diversity, and the path Forward. Rheum Dis Clin North Am. 2022;48(1):199–215.
Singh S, Suri D, Aulakh R, Gupta A, Rawat A, Kumar RM. Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India. Clin Rheumatol. 2014;33(11):1675–9.
Al-Mayouf SM, AlMutiari N, Muzaffer M, Shehata R, Al-Wahadneh A, Abdwani R, et al. Phenotypic characteristics and outcome of juvenile dermatomyositis in arab children. Rheumatol Int. 2017;37(9):1513–7.
Furia FF, Godfrey E, Mwamanenge N, Swai P. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania. Pediatr Rheumatol Online J. 2020;18(1):30.
Article PubMed PubMed Central Google Scholar
Olaosebikan BH, Adelowo OO, Animashaun BA, Akintayo RO. Spectrum of paediatric rheumatic diseases in Nigeria. Pediatr Rheumatol Online J. 2017;15(1):7.
Article PubMed PubMed Central Google Scholar
Prasad S, Misra R, Agarwal V, Lawrence A, Aggarwal A. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade? Int J Rheum Dis. 2013;16(5):556–60.
Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years’ experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for idiopathic inflammatory myopathies. Rheumatology (Oxford). 2011;50(1):137–45.
Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, et al. Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis Care Res (Hoboken). 2014;66(3):404–10.
Huber A, Feldman BM. Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going? Curr Rheumatol Rep. 2005;7(6):441–6.
Guseinova D, Consolaro A, Trail L, Ferrari C, Pistorio A, Ruperto N, et al. Comparison of clinical features and drug therapies among European and latin American patients with juvenile dermatomyositis. Clin Exp Rheumatol. 2011;29(1):117–24.
Sanner H, Gran JT, Sjaastad I, Flatø B. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset. Rheumatology (Oxford). 2009;48(12):1541–7.
Mathiesen PR, Zak M, Herlin T, Nielsen SM. Clinical features and outcome in a Danish cohort of juvenile dermatomyositis patients. Clin Exp Rheumatol. 2010;28(5):782–9.
Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum. 2009;60(11):3425–35.
Article PubMed PubMed Central Google Scholar
Chickermane PR, Mankad D, Khubchandani RP. Disease patterns of juvenile dermatomyositis from Western India. Indian Pediatr. 2013;50(10):961–3.
Chowdhary V, Wakhlu A, Agarwal A, Misra R. Outcome in juvenile dermatomyositis. Indian Pediatr. 2002;39(10):931–5.
Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken). 2010;62(1):63–72.
Sato JO, Sallum AM, Ferriani VP, Marini R, Sacchetti SB, Okuda EM, et al. A Brazilian registry of juvenile dermatomyositis: onset features and classification of 189 cases. Clin Exp Rheumatol. 2009;27(6):1031–8.
Sallum AM, Pivato FC, Doria-Filho U, Aikawa NE, Liphaus BL, Marie SK, et al. Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr (Rio J). 2008;84(1):68–74.
Mussa F, Nalitolela N, Fredrick F. An 8-year-old-girl with juvenile dermatomyositis and autoimmune thyroiditis in Tanzania: a case report. J Med Case Rep. 2021;15(1):632.
Article PubMed PubMed Central Google Scholar
Grijsen ML, McHaile D, Geut I, Olomi R, Nwako M, Requena L, et al. Juvenile dermatomyositis in a 4-year-old Kenyan girl. Clin Case Rep. 2017;5(2):134–8.
Article PubMed PubMed Central Google Scholar
Adelowo O, Nwankwo M, Olaosebikan H. Juvenile dermatomyositis in a Nigerian girl. BMJ Case Rep. 2014;2014.
Aliu R, Aliyu LI, Obiagwu PN, Olatoke L, Ebisike JK. Juvenile dermatomyositis in a 14-year old Nigerian girl. Arch Clin Cases. 2020;7(1):5–9.
Mandengue CE, Nouedoui C, Atangana PJ. [Unrecognized juvenile dermatomyositis complicated by calcinosis universalis: a case report from Cameroon]. Med Sante Trop. 2013;23(4):458–61.
Chinniah KJ, Mody GM. The spectrum of idiopathic inflammatory myopathies in South Africa. Clin Rheumatol. 2021;40(4):1437–46.
Okong’o LO, Esser M, Wilmshurst J, Scott C. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study. Pediatr Rheumatol Online J. 2016;14(1):60.
Article PubMed PubMed Central Google Scholar
Faller G, Mistry BJ, Tikly M. Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014;12:2.
Article PubMed PubMed Central Google Scholar
El-Garf K, El-Garf A, Salah S, Marzouk H, Farag Y, Mostafa N. A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort. Clin Exp Rheumatol. 2022;40(2):450–6.
Phillippi K, Hoeltzel M, Byun Robinson A, Kim S. Race, income, and Disease outcomes in Juvenile Dermatomyositis. J Pediatr. 2017;184:38–e441.
Article PubMed PubMed Central Google Scholar
Wu Q, Wedderburn LR, McCann LJ. Juvenile dermatomyositis: latest advances. Best Pract Res Clin Rheumatol. 2017;31(4):535–57.
Kim H, Huber AM, Kim S. Updates on Juvenile Dermatomyositis from the last decade: classification to outcomes. Rheum Dis Clin North Am. 2021;47(4):669–90.
Article PubMed PubMed Central Google Scholar
Smith S, Juggins A, Evans S, Pilkington C. What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era. Pediatr Rheumatol Online J. 2008;6(Suppl 1):P218–P.
Article PubMed Central Google Scholar
Huber A, Feldman BM. An update on inflammatory myositis in children. Curr Opin Rheumatol. 2013;25(5):630–5.
Article CAS PubMed Google Scholar
Bitnum S, Daeschner CW Jr., Travis LB, Dodge WF, Hopps HC. DERMATOMYOSITIS J Pediatr. 1964;64:101–31.
Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 2005;52(9):2607–15.
Official and Spoken Languages of African Countries. [ https://www.nationsonline.org/oneworld/african_languages.htm
Oluwadiya KS, Olasinde AA, Adeoti AO, Adeoye O, Oluwadiya IO, Kadiri IA. The high cost of healing and teaching: a cross-sectional survey of burnout among academic physicians in Nigeria. BMC Health Serv Res. 2023;23(1):1357.
Comments (0)